|
LRCH1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.211900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.608960E-01 |
| Normal-vs-Stage2 |
1.723450E-01 |
| Normal-vs-Stage3 |
2.07230000004444E-06 |
| Normal-vs-Stage4 |
1.836940E-04 |
| Stage1-vs-Stage2 |
5.163600E-01 |
| Stage1-vs-Stage3 |
1.379690E-04 |
| Stage1-vs-Stage4 |
2.419400E-03 |
| Stage2-vs-Stage3 |
1.196220E-01 |
| Stage2-vs-Stage4 |
1.139380E-01 |
| Stage3-vs-Stage4 |
7.930200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.608000E-04 |
| Normal-vs-AfricanAmerican |
5.154100E-02 |
| Normal-vs-Asian |
7.484200E-01 |
| Caucasian-vs-AfricanAmerican |
9.803000E-01 |
| Caucasian-vs-Asian |
2.020200E-01 |
| AfricanAmerican-vs-Asian |
2.595200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.51010000000374E-05 |
| Normal-vs-Female |
1.776030E-01 |
| Male-vs-Female |
5.758000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.196000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.243000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.81170000004938E-06 |
| Normal-vs-Age(81-100Yrs) |
7.963400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.103800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.794800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.144400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.962200E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.441900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.585000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.059800E-02 |
| Normal-vs-Grade 2 |
4.277400E-01 |
| Normal-vs-Grade 3 |
4.66779999996891E-06 |
| Normal-vs-Grade 4 |
2.01890000000038E-05 |
| Grade 1-vs-Grade 2 |
4.414300E-02 |
| Grade 1-vs-Grade 3 |
4.840900E-04 |
| Grade 1-vs-Grade 4 |
9.396700E-04 |
| Grade 2-vs-Grade 3 |
6.13379999999664E-05 |
| Grade 2-vs-Grade 4 |
9.61769999999751E-05 |
| Grade 3-vs-Grade 4 |
1.063170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.487400E-01 |
| Normal-vs-ccB subtype |
2.9343999996545E-07 |
| ccA subtype-vs-ccB subtype |
2.89930002228544E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.984300E-03 |
| Normal-vs-N1 |
1.048190E-02 |
| N0-vs-N1 |
1.254030E-01 |
|
|
